Violich Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$3.77M |
| 2 |
Linde
LIN
|
+$270K |
| 3 |
O-I Glass
OI
|
+$202K |
| 4 |
SandRidge Energy
SD
|
+$137K |
| 5 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$57.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$14.4M |
| 2 |
Dell
DELL
|
+$8.12M |
| 3 |
FedEx
FDX
|
+$3.85M |
| 4 |
Gilead Sciences
GILD
|
+$2.51M |
| 5 |
SLB Ltd
SLB
|
+$2.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Healthcare | 20.44% |
| 3 | Communication Services | 13.85% |
| 4 | Financials | 11.97% |
| 5 | Consumer Staples | 11.35% |
Similar funds
Violich Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Violich Capital Management held 118 positions worth $352M, down 19% from $438M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Violich Capital Management withdrew a net $38.6M in Q4 2018, closing 9 positions and reducing 64 holdings. Its most notable exit was Aetna Inc, an estimated $14.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Violich Capital Management opened a new position in Linde worth $266K.
- Violich Capital Management's largest Q4 2018 buy was Linde: 1,707 shares worth $266K.
- Violich Capital Management added most to CVS Health in Q4 2018, an estimated $3.77M increase.
- Violich Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $8.12M.
- Violich Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $14.4M.
- Violich Capital Management's ten largest holdings make up 48% of its $352M portfolio in Q4 2018.
- Violich Capital Management opened 3 new positions and closed 9 in Q4 2018.
- Violich Capital Management's portfolio value fell 19% quarter-over-quarter to $352M.
Based on Violich Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.